Biomaterial and cellular implants: foreign surfaces where immunity and coagulation meet

JN Kizhakkedathu, EM Conway - Blood, The Journal of the …, 2022 - ashpublications.org
Exposure of blood to a foreign surface in the form of a diagnostic or therapeutic biomaterial
device or implanted cells or tissue elicits an immediate, evolutionarily conserved …

[HTML][HTML] Platelet activation: a promoter for psoriasis and its comorbidity, cardiovascular disease

Z Jiang, X Jiang, A Chen, W He - Frontiers in Immunology, 2023 - frontiersin.org
Psoriasis is a chronic inflammatory skin disease with a prevalence of 0.14% to 1.99%. The
underlying pathology is mainly driven by the abnormal immune responses including …

Drug–Drug Interaction between Antiplatelet Therapy and Lipid-Lowering Agents (Statins and PCSK9 Inhibitors)

K Schrör, FWA Verheugt, D Trenk - Thrombosis and …, 2023 - thieme-connect.com
Lipid-lowering agents and antiplatelet drugs are guideline-recommended standard
treatment for secondary prevention of acute thrombotic events in patients with increased …

[HTML][HTML] Tissue engineering and targeted drug delivery in cardiovascular disease: the role of polymer nanocarrier for statin therapy

N Montelione, F Loreni, A Nenna, V Catanese, L Scurto… - Biomedicines, 2023 - mdpi.com
Atherosclerosis-related coronary artery disease (CAD) is the leading cause of mortality and
morbidity worldwide. This requires effective primary and secondary prevention in reducing …

[HTML][HTML] Platelet redox imbalance in hypercholesterolemia: a big problem for a small cell

A Morotti, C Barale, E Melchionda, I Russo - International Journal of …, 2022 - mdpi.com
The imbalance between reactive oxygen species (ROS) synthesis and their scavenging by
anti-oxidant defences is the common soil of many disorders, including …

[HTML][HTML] Polymers and nanoparticles for statin delivery: current use and future perspectives in cardiovascular disease

A Nenna, F Nappi, D Larobina, E Verghi, M Chello… - Polymers, 2021 - mdpi.com
Atherosclerosis-related coronary artery disease (CAD) is one of the leading sources of
mortality and morbidity in the world. Primary and secondary prevention appear crucial to …

[HTML][HTML] The Role of Platelets in Infective Endocarditis

MA Braï, N Hannachi, N El Gueddari… - International journal of …, 2023 - mdpi.com
Over the last decade, the incidence of infective endocarditis (IE) has increased, with a
change in the frequency of causative bacteria. Early evidence has substantially …

Recent advances in biopolymer-based hemostatic materials

M Mecwan, J Li, N Falcone, M Ermis… - Regenerative …, 2022 - academic.oup.com
Hemorrhage is the leading cause of trauma-related deaths, in hospital and prehospital
settings. Hemostasis is a complex mechanism that involves a cascade of clotting factors and …

Statin treatment is associated with alterations in the platelet lipidome

T Harm, M Frey, K Dittrich… - Thrombosis and …, 2023 - thieme-connect.com
Background Platelets are key players in the pathophysiology of coronary artery disease
(CAD) and platelet hyperreactivity leads to increased risk of developing adverse …

Molecular Insights into the Relationship Between Platelet Activation and Endothelial Dysfunction: Molecular Approaches and Clinical Practice

N Kazemi, A Bordbar, SS Bavarsad, P Ghasemi… - Molecular …, 2024 - Springer
Platelets are one of the coagulation cells. When platelet activation occurs, many mediators
are released and affect endothelial cells (ECs) and lead to endothelial dysfunction (ED). ED …